Navigation Links
Shorter HCV treatment shows notable success
Date:1/2/2008

Two new randomized controlled trials show that treating Hepatitis C (HCV) with peginterferon and ribavirin for shorter durations can yield success rates similar to those from longer treatment lengths, with cost-savings and lower risk of serious side effects. Patients HCV-RNA levels after 4 weeks of treatment may be an important factor for determining the best treatment length. These findings are in the January issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD). The articles are also available online at Wiley Interscience at (http://www.interscience.wiley.com/journal/hepatology).

HCV genotype is the single most important predictor of a patients outcome after treatment with peginterferon and ribavirin. Only about half of all patients with genotype 1 will achieve a sustained viral response, compared to 70 to 90 percent of patients with genotype 2 or 3. Regardless of HCV genotype, patients who respond quickly to the drugs are also more likely to be cured by them. Based on these differences, and because the therapy is costly and carries risks of serious side effects, researchers have been exploring ways to customize treatment for each patient.

Researchers led by Alessandra Mangia of Italys Istituto di Ricovero e Cura a Carattere Scientifico, Casa Sollievo Della Sofferenza, in San Giovanni Rotondo conducted a randomized controlled trial of patients with HCV genotype 1. They hypothesized that variable treatment duration based on the first measurement of undetectable HCV RNA would be as effective as standard 48-week treatment. They enrolled 696 patients, 237 of whom received standard HCV. The remaining 459 were treated for 24, 48, or 72 weeks, if HCV-RNA was undetectable at 4, 8, or 12 weeks, respectively.

Nearly 49 percent of patients receiving variable treatment based on detectable viral
'/>"/>

Contact: Amy Molnar
amolnar@wiley.com
Wiley-Blackwell
Source:Eurekalert

Page: 1 2

Related medicine news :

1. First in the World Live Case Using New Technology Demonstrates Shorter Procedure Time
2. Shorter Legs Might Boost Liver Risks
3. New treatment effective in counteracting cocaine-induced symptoms
4. New treatment boosts muscle function in myasthenia gravis
5. Broad-based group of physicians calls for improvement in stroke treatment
6. Cranberry Could Juice Up Ovarian Cancer Treatment
7. Non-medicinal treatment touted for pre-schoolers with ADHD
8. Nonmedicinal treatment touted for preschoolers with ADHD
9. U of M study: Early treatment can reverse heart damage
10. Biologic treatment for rheumatoid arthritis and the risk of cancer
11. New Treatment Explored for Cluster Headaches
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... could be linked to scans performed in 2007 , , ... are exposing patients to far more radiation than previously thought ... cancers a year, two new studies claim. , Based on ... Archives of Internal Medicine , the study authors, joined ... calling on clinicians to limit radiation exposure to patients. , ...
(Date:12/14/2009)... Type 2 diabetes and obesity are linked to an ... suggested that insulin glargine (a synthetic insulin preparation marketed ... a higher risk of certain cancers than other insulins ... were unable to control for important factors such as ... On the other hand, a large randomized trial designed ...
(Date:12/14/2009)... for meth and smoking, but concerns about prescription ... -- Fewer teenagers are using methamphetamine, but reductions ... prescription drugs remains high, U.S. health officials report. ... such as the hallucinogenic salvia leaf and the ... of attention-deficit hyperactivity disorder (ADHD), appear to be ...
(Date:12/14/2009)... Health Workforce Recommendations are Implemented ,, ... must ensure that health reform includes a ... to ensure implementation of an integrated, coordinated ... Steven A Wartman, president and CEO of ... "With each step in the legislative ...
(Date:12/14/2009)... is a statement of Matthew L. Myers, President, ... ) ,, The 2009 Monitoring the Future Survey ... Abuse shows that the nation continues to make ... have slowed significantly compared to the dramatic gains ... news, the survey also finds that smokeless tobacco ...
Breaking Medicine News(10 mins):Health News:Studies Quantify Cancer Risks From CT Scans 2Health News:Studies Quantify Cancer Risks From CT Scans 3Health News:Studies Quantify Cancer Risks From CT Scans 4Health News:UNC scientists coordinate study of link between insulin use and cancer in people with diabetes 2Health News:Marijuana Use No Longer Dropping Among U.S. Teens 2Health News:Marijuana Use No Longer Dropping Among U.S. Teens 3Health News:Marijuana Use No Longer Dropping Among U.S. Teens 4Health News:Health Reform Needs Enforceable National Workforce Strategy 2Health News:New Survey Shows Slow Decline in Youth Smoking, Troubling Increase in Smokeless Tobacco Use - Congress, States Must Step Up Tobacco Prevention Efforts 2Health News:New Survey Shows Slow Decline in Youth Smoking, Troubling Increase in Smokeless Tobacco Use - Congress, States Must Step Up Tobacco Prevention Efforts 3Health News:New Survey Shows Slow Decline in Youth Smoking, Troubling Increase in Smokeless Tobacco Use - Congress, States Must Step Up Tobacco Prevention Efforts 4Health News:New Survey Shows Slow Decline in Youth Smoking, Troubling Increase in Smokeless Tobacco Use - Congress, States Must Step Up Tobacco Prevention Efforts 5
... a recent study researchers from Sweden say they have ... with coronary vasoconstriction in areas adjacent to the treated ... ,Sirolimus-eluting stents are widely used for percutaneous ... angiographic outcome, however, recent concerns have been raised that ...
... yoga can reduce the bulging girth of the abdomen in middle ... Research Center who have conducted a study showed that regular practice ... or more years can lead to arrest of weight gain in ... the data collected from 15,500 men and women in the age ...
... Bihar High Court on Tuesday ordered the Patna Medical College ... immediately. This order came after hearing a filed petition, that ... Friday. ,The death of several critical patients due ... to the intervention of the Bihar High Court. The Hospital ...
... that when it comes to treating their children with urinary ... the parents to rely on the folk medicines like cranberry ... of the time the usage of such types of folk ... ,Researchers for the study feel that this brings out in ...
... has shown that handwashing ,with soap prevents the two ... infections. ,These two infections have been identified ... years of age ,every year in the developing couintries, ... groups. ,In the current study done in the squatter ...
... investigators from Sahlgrenska University Hospital in Gothenburg, Sweden,// had ... the health condition called drug-induced liver disease. ,Drug ... when the medication is withdrawn, some effects of this ... fatal. An observation made by Dr. Hyman Zimmerman and ...
Other Medicine News:Health News:Analyzing The Side Effects Of Sirolimus Stents 2
(Date:12/14/2009)... Accuray Incorporated (Nasdaq: ARAY ), a global ... that the first CyberKnife® Robotic Radiosurgery System in ... of Liege. ,, The University Hospital in ... largest hospitals in Euregio, a cross-country region of ... range of cancer treatments, University Hospital of Liege ...
(Date:12/14/2009)... INDIANAPOLIS, Dec. 14 The ... RELPREVV (olanzapine) For Extended Release Injectable Suspension for ... and Company (NYSE: LLY ) announced ... the delivery of olanzapine for up to four ... short-acting formulations, long-acting formulations of antipsychotics allow for ...
(Date:12/14/2009)... CPG International, Inc., manufacturer of market-leading brands ... a rebranded business unit. ,, Following the ... Scranton Products Industrial business entities, VYCOM is ... CPG International, Inc. alongside AZEK Building Products ... unit has new, redefined and dedicated organization ...
Breaking Medicine Technology:First CyberKnife in Belgium to be Installed at Leading University Hospital 2First CyberKnife in Belgium to be Installed at Leading University Hospital 3FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 2FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 3FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 4FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 5FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 6FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 7FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 8CRH Medical reports Q3 2009 results 62298 1CRH Medical reports Q3 2009 results 62298 2CRH Medical reports Q3 2009 results 62298 3NCOA Bedlin Brief Leading Aging Organizations on Health Care Reform Needed Long Term Care Provisions 62296 1NCOA Bedlin Brief Leading Aging Organizations on Health Care Reform Needed Long Term Care Provisions 62296 2Kool Smiles Named Among 2009 InfoWorld 100 62294 1Kool Smiles Named Among 2009 InfoWorld 100 62294 2
... resulting from,influenza, often referred to as "the flu," is ... with any other chronic medical,condition. However, according to a ... Interactive on behalf of Mended Hearts, Inc.,a national heart ... more than one in three heart disease patients (37%) ...
... 1 The U.S. Department of,Health and Human ... and,the Ministry of Health of the United Mexican ... in the surveillance,prevention, and control of infectious diseases ... of life of their peoples. The Memorandum ...
Other Medicine Technology:Despite Serious Health Risks, One in Three Adults with Heart Disease Does Not Believe They Need a Flu Shot This Year 2Despite Serious Health Risks, One in Three Adults with Heart Disease Does Not Believe They Need a Flu Shot This Year 3Despite Serious Health Risks, One in Three Adults with Heart Disease Does Not Believe They Need a Flu Shot This Year 4United States, Canada and Mexico Agree to Mutual Assistance During Public Health Emergencies 2
... the new PRONEB® ULTRA compressor. This high ... while delivering more medication to the patient's ... PLUS® or PARI LC STAR® Reusable Nebulizer, ... for inhalation and retention into the lungs. ...
... Graham-Field has been developing diverse ... 58 years. Our medical-surgical products ... for innovation, quality and customer ... include the Labtron® line of ...
... TREK™ Compact Compressor is for active patients ... anywhere and everywhere. The compressor is small ... source optionsworldwide AC compatibility (100 to 240V), ... patients the freedom to take aerosol treatments ...
... ,Allied Healthcares Timeter® PCS 414 portable air compressor ... that you may wonder if its running. Youll ... a durable, mar-resistant steel case thats easy to ... 26.5 pounds. The PCS 414 has been engineered ...
Medicine Products: